·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ¼¿ï½Ã¾à, ¾à»ç±¹½Ã ÇöÀå ¹æ¹®ÇØ ¼öÇè»ýµé °Ý·Á ±â»çÀÔ·Â : 20.01.22 17:17:22 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] ¼¿ï½Ã¾à»çȸ(ȸÀå Çѵ¿ÁÖ)´Â 22ÀÏ ¿ÀÀü 7½Ã 30ºÐ Á¦71ȸ ¾à»ç±¹°¡½ÃÇèÀÌ ¿¸®´Â ±¸·Î±¸ ¼ÒÀç ½Åµµ¸²ÁßÇб³¸¦ ¹æ¹®ÇØ ¼öÇè»ýµéÀÇ ÇÕ°ÝÀ» ±â¿øÇß´Ù°í ¹àÇû´Ù. À̳¯ ¹æ¹®¿¡´Â Çѵ¿ÁÖ È¸Àå°ú ÀÌÁø¼ø¡¤±èÈ¸í¡¤À̸íÀÚ¡¤ÀåÇöÁø ºÎȸÀå, ¹èÈÆ ¾à¹Ù·Î¾²±â¿îµ¿º»ºÎÀå, ±è¿µÁø Ãѹ«ÀÌ»ç, ±³¹®·Ï ±¹Á¦ÀÌ»ç, ±èÀº±³ û³â¾à»çÀ̻簡 Âü¼®Çß´Ù. Çѵ¿ÁÖ È¸ÀåÀº "Áö³ 6³âÀ» Àß À̰ܳ»°í ¿©±â±îÁö ¿Â ¼öÇè»ý ¿©·¯ºÐµé¿¡°Ô ÈûÂù ÀÀ¿øÀÇ ¹Ú¼ö¸¦ º¸³½´Ù"¸ç "±×°£ °¥°í ´Û¾Æ¿Â ³ë·ÂÀÇ °á°ú°¡ ÃÖ´ëÇÑ ¹ßÈÖµÇ±æ ¹Ù¶ó¸ç ¹«¾ùº¸´Ù Æí¾ÈÇÏ°Ô ½ÃÇè º¸±â¸¦ ¹Ù¶õ´Ù"°í °Ý·ÁÇß´Ù. ½Ã¾à»çȸ´Â À̳¯ ¼öÇè»ýµé¿¡°Ô ¾à»ç¸éÇãÁõ ¹ß±Þ ÀýÂ÷, ¾à»çȸ ½Å»ó½Å°í ¹æ¹ý, ±Ù·Î±âÁعý, ¾àÈ»ç°í ´ëÀÀ¿ä·É, ¿¬¼ö±³À° ¾È³» µî »õ³»±â¾à»ç¸¦ À§ÇÑ ³»¿ëÀÌ ´ã±ä ÇÚµåºÏ°ú »çÀÎÆæ, ºñŸ¹Î À½·á¸¦ Àü´ÞÇß´Ù. X AD ÇÇÁö¿À¸Ó¿Í ÇÔ²²! À̺¥Æ®Âü¿© ¡æ ±èÁöÀº ±âÀÚ(bob83@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÇԾȰøÀå Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿ï½Ã¾à, ¾à»ç±¹½Ã ÇöÀå ¹æ¹®ÇØ ¼öÇè»ýµé °Ý·Á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¼¿ï½Ã¾à, ¾à»ç±¹½Ã ÇöÀå ¹æ¹®ÇØ ¼öÇè»ýµé °Ý·Á ±â»çÀÔ·Â : 20.01.22 17:17:22 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] ¼¿ï½Ã¾à»çȸ(ȸÀå Çѵ¿ÁÖ)´Â 22ÀÏ ¿ÀÀü 7½Ã 30ºÐ Á¦71ȸ ¾à»ç±¹°¡½ÃÇèÀÌ ¿¸®´Â ±¸·Î±¸ ¼ÒÀç ½Åµµ¸²ÁßÇб³¸¦ ¹æ¹®ÇØ ¼öÇè»ýµéÀÇ ÇÕ°ÝÀ» ±â¿øÇß´Ù°í ¹àÇû´Ù. À̳¯ ¹æ¹®¿¡´Â Çѵ¿ÁÖ È¸Àå°ú ÀÌÁø¼ø¡¤±èÈ¸í¡¤À̸íÀÚ¡¤ÀåÇöÁø ºÎȸÀå, ¹èÈÆ ¾à¹Ù·Î¾²±â¿îµ¿º»ºÎÀå, ±è¿µÁø Ãѹ«ÀÌ»ç, ±³¹®·Ï ±¹Á¦ÀÌ»ç, ±èÀº±³ û³â¾à»çÀ̻簡 Âü¼®Çß´Ù. Çѵ¿ÁÖ È¸ÀåÀº "Áö³ 6³âÀ» Àß À̰ܳ»°í ¿©±â±îÁö ¿Â ¼öÇè»ý ¿©·¯ºÐµé¿¡°Ô ÈûÂù ÀÀ¿øÀÇ ¹Ú¼ö¸¦ º¸³½´Ù"¸ç "±×°£ °¥°í ´Û¾Æ¿Â ³ë·ÂÀÇ °á°ú°¡ ÃÖ´ëÇÑ ¹ßÈÖµÇ±æ ¹Ù¶ó¸ç ¹«¾ùº¸´Ù Æí¾ÈÇÏ°Ô ½ÃÇè º¸±â¸¦ ¹Ù¶õ´Ù"°í °Ý·ÁÇß´Ù. ½Ã¾à»çȸ´Â À̳¯ ¼öÇè»ýµé¿¡°Ô ¾à»ç¸éÇãÁõ ¹ß±Þ ÀýÂ÷, ¾à»çȸ ½Å»ó½Å°í ¹æ¹ý, ±Ù·Î±âÁعý, ¾àÈ»ç°í ´ëÀÀ¿ä·É, ¿¬¼ö±³À° ¾È³» µî »õ³»±â¾à»ç¸¦ À§ÇÑ ³»¿ëÀÌ ´ã±ä ÇÚµåºÏ°ú »çÀÎÆæ, ºñŸ¹Î À½·á¸¦ Àü´ÞÇß´Ù. X AD ÇÇÁö¿À¸Ó¿Í ÇÔ²²! À̺¥Æ®Âü¿© ¡æ ±èÁöÀº ±âÀÚ(bob83@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÇԾȰøÀå Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿ï½Ã¾à, ¾à»ç±¹½Ã ÇöÀå ¹æ¹®ÇØ ¼öÇè»ýµé °Ý·Á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¼¿ï½Ã¾à, ¾à»ç±¹½Ã ÇöÀå ¹æ¹®ÇØ ¼öÇè»ýµé °Ý·Á ±â»çÀÔ·Â : 20.01.22 17:17:22 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] ¼¿ï½Ã¾à»çȸ(ȸÀå Çѵ¿ÁÖ)´Â 22ÀÏ ¿ÀÀü 7½Ã 30ºÐ Á¦71ȸ ¾à»ç±¹°¡½ÃÇèÀÌ ¿¸®´Â ±¸·Î±¸ ¼ÒÀç ½Åµµ¸²ÁßÇб³¸¦ ¹æ¹®ÇØ ¼öÇè»ýµéÀÇ ÇÕ°ÝÀ» ±â¿øÇß´Ù°í ¹àÇû´Ù. À̳¯ ¹æ¹®¿¡´Â Çѵ¿ÁÖ È¸Àå°ú ÀÌÁø¼ø¡¤±èÈ¸í¡¤À̸íÀÚ¡¤ÀåÇöÁø ºÎȸÀå, ¹èÈÆ ¾à¹Ù·Î¾²±â¿îµ¿º»ºÎÀå, ±è¿µÁø Ãѹ«ÀÌ»ç, ±³¹®·Ï ±¹Á¦ÀÌ»ç, ±èÀº±³ û³â¾à»çÀ̻簡 Âü¼®Çß´Ù. Çѵ¿ÁÖ È¸ÀåÀº "Áö³ 6³âÀ» Àß À̰ܳ»°í ¿©±â±îÁö ¿Â ¼öÇè»ý ¿©·¯ºÐµé¿¡°Ô ÈûÂù ÀÀ¿øÀÇ ¹Ú¼ö¸¦ º¸³½´Ù"¸ç "±×°£ °¥°í ´Û¾Æ¿Â ³ë·ÂÀÇ °á°ú°¡ ÃÖ´ëÇÑ ¹ßÈÖµÇ±æ ¹Ù¶ó¸ç ¹«¾ùº¸´Ù Æí¾ÈÇÏ°Ô ½ÃÇè º¸±â¸¦ ¹Ù¶õ´Ù"°í °Ý·ÁÇß´Ù. ½Ã¾à»çȸ´Â À̳¯ ¼öÇè»ýµé¿¡°Ô ¾à»ç¸éÇãÁõ ¹ß±Þ ÀýÂ÷, ¾à»çȸ ½Å»ó½Å°í ¹æ¹ý, ±Ù·Î±âÁعý, ¾àÈ»ç°í ´ëÀÀ¿ä·É, ¿¬¼ö±³À° ¾È³» µî »õ³»±â¾à»ç¸¦ À§ÇÑ ³»¿ëÀÌ ´ã±ä ÇÚµåºÏ°ú »çÀÎÆæ, ºñŸ¹Î À½·á¸¦ Àü´ÞÇß´Ù. X AD ÇÇÁö¿À¸Ó¿Í ÇÔ²²! À̺¥Æ®Âü¿© ¡æ ±èÁöÀº ±âÀÚ(bob83@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿ï½Ã¾à, ¾à»ç±¹½Ã ÇöÀå ¹æ¹®ÇØ ¼öÇè»ýµé °Ý·Á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö